Huons BioPharma
Huons BioPharma
Pioneering the Future of Aesthetic and Therapeutic Biologics
Huons BioPharma is a specialized biopharmaceutical powerhouse within the Huons Group, dedicated to the advanced development of botulinum toxin formulations. Strategically positioned as a global leader, the company focuses on accelerating the expansion of its toxin portfolio while pioneering next generation treatments for intractable diseases. By integrating cutting edge biotechnology with clinical expertise, Huons BioPharma contributes significantly to the sustainable growth of the broader Huons “Total Healthcare” vision.
About Huons BioPharma
Building on Decades of Pharmaceutical Leadership
Founded as a specialized arm of Huons Global, Huons BioPharma inherits over 60 years of pharmaceutical heritage. While the parent group provides a stable foundation of “Total Healthcare” expertise, our specific mission is to lead the “Bio Revolution.” We are dedicated to becoming a top tier global biopharmaceutical company through aggressive R&D investment and a relentless pursuit of excellence.
Why Choose Huons BioPharma?
Precision, Reliability, and Global Excellence in Every Vial
Manufacturing Powerhouse
We utilize world class sterile production facilities that meet rigorous international regulatory standards.
Clinical Diversity
Our research focuses on expanding indications, moving beyond aesthetics into life changing medical applications.
Global Distribution Network
With an established footprint in key markets like the US and Japan, we offer seamless global accessibility.
Brand philosophy
A Human Centric Approach to Global Total Healthcare
Quality First: We never compromise on the safety and efficacy of our biopharmaceutical products.
Integrity Driven Innovation: Our R&D is focused on solving real world medical challenges and intractable diseases.
Holistic Growth: We aim to enrich the lives of patients and practitioners by creating a sustainable “Total Healthcare” ecosystem.
Product System
Our biopharmaceutical ecosystem is centered around two flagship botulinum toxin formulations, engineered for high purity and clinical efficacy across aesthetic and therapeutic indications.
HUTOX Inj. 100 Units
Targeted aesthetic treatments such as forehead transverse lines and glabellar (frown) lines.
HUTOX Inj. 200 Units
Broad area aesthetic work or medical applications including muscle spasticity and hyperhidrosis